Safety and Efficacy of Kygevvi in Thymidine Kinase 2 Deficiency by Madaline Spencer| Published on: Aug 11, 2026

Safety and Efficacy of Kygevvi in Thymidine Kinase 2 Deficiency by Madaline Spencer| Published on: Aug 11, 2026 Caterina Garone, PhD, MD, Associate Professor at the University of Bologna, discusses safety and efficacy data on Kygevvi (doxecitine and doxribtimine) in patients with thymidine kinase 2 deficiency (TK2d). https://checkrare.com/safety-and-efficacy-of-kygevvi-in-thymidine-kinase-2-deficiency/